Quantcast

Posts related to ‘Qnexa’

76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

Posted: December 18, 2012 at 10:43 am

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »

Weight Loss Drugs Eating Up FDA Approval

Posted: July 18, 2012 at 9:05 am

The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

Posted: April 10, 2012 at 7:11 am

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

Posted: February 22, 2012 at 4:36 pm

VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday.  The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing ...
Read Full Story »

BioWatch: VIVUS & Orexigen Looking More FDA-Favorable (VVUS, OREX, ARNA)

Posted: April 4, 2011 at 9:38 am

VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning is showing why VIVUS may be one of the only ...
Read Full Story »